ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 205 filers reported holding ISIS PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 1.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2015 | $40,025,000 | -29.4% | 990,262 | +0.5% | 0.04% | -18.5% |
Q2 2015 | $56,723,000 | -2.5% | 985,631 | +7.8% | 0.05% | -3.6% |
Q1 2015 | $58,193,000 | +25.5% | 913,980 | +21.7% | 0.06% | +27.3% |
Q4 2014 | $46,360,000 | +50.8% | 750,897 | -5.2% | 0.04% | +46.7% |
Q3 2014 | $30,742,000 | +17.7% | 791,697 | +4.4% | 0.03% | +15.4% |
Q2 2014 | $26,113,000 | +44.6% | 757,997 | +81.3% | 0.03% | +36.8% |
Q1 2014 | $18,062,000 | +26.9% | 417,997 | +17.0% | 0.02% | +18.8% |
Q4 2013 | $14,231,000 | +64.6% | 357,197 | +55.1% | 0.02% | +45.5% |
Q3 2013 | $8,648,000 | +550.2% | 230,357 | +365.4% | 0.01% | +450.0% |
Q2 2013 | $1,330,000 | – | 49,497 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BB BIOTECH AG | 7,202,585 | $270,385,000 | 14.71% |
DOWLING & YAHNKE LLC | 675,798 | $25,369,000 | 3.98% |
GARRISON BRADFORD & ASSOCIATES INC | 100,700 | $3,780,000 | 3.87% |
WILLIAM HARRIS INVESTORS INC | 312,834 | $11,743,000 | 3.67% |
Meditor Group Ltd | 490,000 | $18,395,000 | 2.59% |
AVALON CAPITAL MANAGEMENT | 50,943 | $1,912,000 | 1.89% |
Orinda Asset Management LLC | 14,665 | $551,000 | 1.73% |
PINNACLE ASSOCIATES LTD | 2,064,760 | $77,511,000 | 1.60% |
PERKINS CAPITAL MANAGEMENT INC | 52,850 | $1,984,000 | 1.43% |
NCM Capital Advisers, Inc. | 24,950 | $937,000 | 1.04% |